Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterisation of the Nasal Microbiome in Patients Suffering From Non-steroidal Anti-inflammatory Drugs-exacerbated Respiratory Disease (N-ERD) - a Pilot Study

NCT04375293 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT04375293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04375293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterisation of the Nasal Microbiome in Patients Suffering From Non-steroidal Anti-inflammatory Drugs-exacerbated Respiratory Disease (N-ERD) - a Pilot Study
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Completed
Start date
January 7, 2020
Completion date
July 25, 2021
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin exacerbated respiratory disease, chronic rhinitis